Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company September 21, 2023 Press Releases
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally August 2, 2023 Press Releases
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit May 18, 2023 Press Releases
Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China May 15, 2023 Press Releases
Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes January 12, 2023 Press Releases
Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes January 4, 2023 Press Releases
